In Canada, Oligo Medic, a medical device company that develops biomaterials for regenerative medicine and is known for JointRep for cartilage treatment in body joints, has a new CEO, Jerett A. Creed. Creed’s career started with Johnson and Johnson focusing on angioplasty balloons and metal stents, as CFO of a publicly traded oil and gas company and CEO of Cardigant Medical, but has evolved with his 20 years of experience in the medical technology field. Creed led Oligo Medic’s launch of their JointRep product in Latin America. He has also been involved in 2 public offerings as well as more than $650 million merger and acquisition activities for Oligo Medic.
Latest article
Snack rats eat biobased fiber optic cables, send London’s G.Network into bankruptcy
In the United Kingdom, London internet provider G.Network has entered administration because it used fiber optic cable jackets made of soy- and corn-based materials...
Samsung creates e-paper with phytoplankton display
In South Korea, Samsung Electronics has unveiled an e-paper with a display made of phytoplankton-based plastics.
E‑paper is a display technology that replicates the...
Make Good launches mushroom-based shoes
In Australia, shoe brand Make Good has created a Derby shoe style with a variety of biobased materials. Dubbed Derby V1, the shoe includes...